Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$32.75 – $62.59
64% from low
Exchange
ARCX
ETF
No company description on file.
No one on the platform currently holds CNXT.
No tracked institution reports a position in CNXT as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-22 | $0.0788 | 2025-12-26 |
| 2024-12-23 | $0.0401 | 2024-12-24 |
| Execution date | Ratio |
|---|---|
| 2008-06-30 | 1-for-10reverse |
No one on the platform has traded CNXT yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| CNXTVanEck ChiNext ETF | $51.88 | +0.51% | $114M | — |
| FMEDFidelity Disruptive Medicine ETF | $30.23 | +0.33% | $69M | — |
| FTCEFirst Trust New Constructs Core Earnings Leaders ETF | $28.14 | +0.16% | $84M | — |
| JANTAllianzIM U.S. Equity Buffer10 Jan ETF | $45.15 | +0.08% | $64M | — |
| KOOLNorth Shore Equity Rotation ETF | $14.92 | +0.00% | $61M | — |
| LCFTouchstone US Large Cap Focused ETF | $46.72 | +0.00% | $67M | — |
| NULCNuveen ESG Large-Cap | $56.84 | -0.05% | $68M | — |
Source: Financial Modeling Prep · peers by sector/industry
@AdamantiumBull Yeah that's a good point, I saw that yesterday - but I would still think the constituents in $CNXT would benefit from that development. Maybe they are just being tossed with the group.
View on StockTwits ↗If $MU $COHR $LRCX $SNDK is all down because of the entry of CXMT (taking like 4% market share and been around for years) then how is CXMT and the constituents of the $CNXT also down? Makes no sense to me aside from algo-trade-slop.
View on StockTwits ↗i think people are sleeping on the HBM opportunity in China since they're effectively locked out. They have to manufacture their own. yields are lower at 50% vs. 75-80% for SK Hynix. But that just means more investment. Styaing long $CNXT and $ACMR ahead of CMXT shanghai ipo for that exposure.
View on StockTwits ↗This week’s international board had one very loud message: ➡️ China innovation: $KSTR ➡️ China growth: $CNXT ➡️ China small caps: $ASHS ➡️ South Korea broad exposure: $FLKR ➡️ Global IPO growth: $FPXI The global rally did not show up everywhere equally, but it did show up where investors could get direct exposure to Asia’s growth, hardware, innovation, and newer-public-company stories. Track global ETF performance and compare the baskets on ETFDb: https://etfdb.com/screener/ (7/7)
View on StockTwits ↗2️⃣ $CNXT — VanEck ChiNext Innovators ETF 📈 5D Return: +7.78% 💸 Expense Ratio: 0.65% $CNXT kept the same China-innovation theme going, with exposure to growth-oriented companies across technology, healthcare, advanced manufacturing, and clean energy. So far, the board is saying investors were not looking for the old China trade. They were looking for the companies trying to build the next one. (3/7)
View on StockTwits ↗$CNXT Considering an entry here, but it keeps running away from me! 😁
View on StockTwits ↗$CNXT The investment setup is entering a phase where operational credibility carries greater weight. Margins must remain resilient as activity scales. If milestones track on schedule, sentiment can re-rate faster than fundamentals. Without confirmation, volatility likely persists.
View on StockTwits ↗$CNXT Current Stock Price: $42.84 Contracts to trade: $45 CNXT Nov 21 2025 Call Entry: $0.32 Exit: $0.61 ROI: 94% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.